...
机译:通过诱导对Toll样受体7的耐受来预防自身免疫性疾病
Moores Cancer Center, University California at San Diego, La Jolla, CA 92093;
Moores Cancer Center, University California at San Diego, La Jolla, CA 92093;
Moores Cancer Center, University California at San Diego, La Jolla, CA 92093;
Moores Cancer Center, University California at San Diego, La Jolla, CA 92093;
Department Medicine, University California at San Diego, La Jolla, CA 92093;
Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105;
National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892;
Moores Cancer Center, University California at San Diego, La Jolla, CA 92093;
Department Medicine, University California at San Diego, La Jolla, CA 92093;
arthritis; encephalomyelitis; synthetic agonist;
机译:Toll样受体信号通路在自身免疫性疾病的诱导和发展中的关键作用。
机译:Toll样受体信号通路在自身免疫性疾病的诱导和进展中的关键作用
机译:表达用于预防/治疗自身免疫,过敏和炎症性疾病的抗原的转基因植物诱导的口服耐受性
机译:Toll样受体在全身自身免疫病中的作用
机译:免疫调节治疗用于预防自身免疫性糖尿病和实验性胰岛移植诱导的诱导
机译:通过诱导对Toll样受体7的耐受来预防自身免疫性疾病
机译:通过诱导对Toll样受体7的耐受来预防自身免疫性疾病